0
Skip to Content
=
Home
The Navocator Newsletter
About
=
Home
The Navocator Newsletter
About
Home
The Navocator Newsletter
About

Subscribe to Stay Ahead in Medicine and Your Care

We respect your privacy

Thank you!
Inside UCLA’s Effort to End Required Lifelong Transplant Anti-Rejection Drugs
Transplant Medicine, Transplant Innovation Ali Dugger 11/30/25 Transplant Medicine, Transplant Innovation Ali Dugger 11/30/25

Inside UCLA’s Effort to End Required Lifelong Transplant Anti-Rejection Drugs

For decades, surviving a transplant has meant taking powerful anti-rejection drugs for life. A UCLA clinical trial using donor stem cells is testing whether retraining the immune system could finally change that tradeoff…

Read More

Empowering Advocacy & Care Navigation

info@navocatehealth.com